Single-Blind Randomized Controlled Trial of Poly-Herbal Formula Sahatsatara for Acute Low Back Pain: A Pilot Study

Authors

  • Somruedee Chatsiricharoenkul Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700

Abstract

Objective: To evaluate the efficacy and safety of poly-herbal formula Sahatsatara (SHT) in pain reduction in acute low back pain (LBP) patients.
Methods: Twenty-nine patients aged 18-65 years with a history of moderate to severe acute LBP ≤3-day (score ≥4 on a 0-10 numeric rating scale [NRS]) were enrolled and randomized to receive an ibuprofen (400 mg after meals three times daily) or SHT (1,350 mg before meals three times daily) for 7 days. The non-inferiority trial margin was set at ±10 percentage points. The outcomes were measured on pain intensity on the 0-10 NRS, disability on the Thai version of the Oswestry disability index [ODI], total analgesic consumption, patient satisfaction, and safety.
Results: Fourteen patients and 15 patients were randomly allocated to ibuprofen and SHT groups, respectively. The mean difference in pain intensity and disability between the two groups at day 7 adjusted according to baseline was within ±1 for pain (-0.3; 95% CI, -1.48 to 0.96) and ±10% (-4.9%; 95% CI, -14.86% to 5.02%) for the NRS and ODI scores, respectively. One patient in the SHT group and 5 in the ibuprofen group had gastrointestinal irritation, but the difference was not statistically significant.
Conclusion: SHT was not inferior to ibuprofen in pain relieving and disability in patients with acute LBP. The result suggests a role for SHT as an alternative analgesic in acute LBP. (Thai Clinical Trials Registry number 20141027001)

Keywords: Acute low back pain, poly-herbal formula Sahatsatara, ibuprofen

Downloads

Published

09-03-2016

How to Cite

Chatsiricharoenkul, S. (2016). Single-Blind Randomized Controlled Trial of Poly-Herbal Formula Sahatsatara for Acute Low Back Pain: A Pilot Study. Siriraj Medical Journal, 68(1), 30–36. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/55203

Issue

Vol. 68 No. 1 (2016): January-February

Section

Original Article

License

Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:

  • Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.